These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 9367070)
1. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070 [TBL] [Abstract][Full Text] [Related]
2. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Moon TE; Levine N; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):949-56. PubMed ID: 9367069 [TBL] [Abstract][Full Text] [Related]
3. Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group. Moon TE; Levine N; Cartmel B; Bangert J; Rodney S; Schreiber M; Peng YM; Ritenbaugh C; Meyskens F; Alberts D Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):661-9. PubMed ID: 8547834 [TBL] [Abstract][Full Text] [Related]
4. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591 [TBL] [Abstract][Full Text] [Related]
5. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA; J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281 [TBL] [Abstract][Full Text] [Related]
6. Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence. Clouser MC; Roe DJ; Foote JA; Harris RB; Alberts DS Nutr Cancer; 2010; 62(8):1058-66. PubMed ID: 21058193 [TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group. Tangrea JA; Adrianza E; Helsel WE; Taylor PR; Hartman AM; Peck GL; Edwards BK Cancer Epidemiol Biomarkers Prev; 1993; 2(4):375-80. PubMed ID: 8348061 [TBL] [Abstract][Full Text] [Related]
9. Cancer protection in xeroderma pigmentosum variant (XP-V). Somos S; Farkas B; Schneider I Anticancer Res; 1999; 19(3B):2195-9. PubMed ID: 10472330 [TBL] [Abstract][Full Text] [Related]
10. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046 [TBL] [Abstract][Full Text] [Related]
11. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064 [TBL] [Abstract][Full Text] [Related]
12. Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancer. Dorgan JF; Boakye NA; Fears TR; Schleicher RL; Helsel W; Anderson C; Robinson J; Guin JD; Lessin S; Ratnasinghe LD; Tangrea JA Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1276-82. PubMed ID: 15298946 [TBL] [Abstract][Full Text] [Related]
13. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma. Jones E; Korzenko A; Kriegel D J Drugs Dermatol; 2004; 3(5):498-502. PubMed ID: 15552602 [TBL] [Abstract][Full Text] [Related]
14. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. Greenberg ER; Baron JA; Stukel TA; Stevens MM; Mandel JS; Spencer SK; Elias PM; Lowe N; Nierenberg DW; Bayrd G N Engl J Med; 1990 Sep; 323(12):789-95. PubMed ID: 2202901 [TBL] [Abstract][Full Text] [Related]
15. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780 [TBL] [Abstract][Full Text] [Related]
16. High sun protection factor sunscreens in the suppression of actinic neoplasia. Naylor MF; Boyd A; Smith DW; Cameron GS; Hubbard D; Neldner KH Arch Dermatol; 1995 Feb; 131(2):170-5. PubMed ID: 7857113 [TBL] [Abstract][Full Text] [Related]
17. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. van der Pols JC; Williams GM; Pandeya N; Logan V; Green AC Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2546-8. PubMed ID: 17132769 [TBL] [Abstract][Full Text] [Related]
19. Patients' perceptions on participation in a cancer chemoprevention trial. Tangrea JA; Adrianza ME; Helsel WE Cancer Epidemiol Biomarkers Prev; 1992; 1(4):325-30. PubMed ID: 1303133 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]